SCHEMBL30123583

SCHEMBL30123583

N=C(N)NCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 13/20 0.59
▸ NPY1R P25929 7/20 0.59
▸ NPY2R P49146 5/20 0.59
▸ NPY5R Q15761 5/20 0.59
▸ KISS1R Q969F8 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30392283 0.96 NPY4R (0.61) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30490565 0.95 NPY4R (0.55) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30198606 0.94 NPY4R (0.66) NPY4RNPY1RNPY2RNPY5R
Kyotorphin SCHEMBL2889815 0.94 NPY4R (0.62) NPY4RNPY1RNPY2RNPY5R
Kyotorphin SCHEMBL248289 0.94 NPY4R (0.62) NPY4RNPY1RNPY2RNPY5R
D[-Arg-2]Kyotorphan Acetate SCHEMBL29780328 0.94 NPY4R (0.62) NPY4RNPY1RNPY2RNPY5R
Kyotorphin SCHEMBL248288 0.94 NPY4R (0.62) NPY4RNPY1RNPY2RNPY5R
SCHEMBL31155494 0.93 NPY4R (0.67) NPY4RNPY1RNPY2RNPY5R
SCHEMBL30974038 0.92 NPY4R (0.60) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL29434645 0.92 NPY4R (0.73) NPY4RNPY1RNPY2RNPY5RKISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024132726-A1 SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF ACUTE ISCHEMIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF ACUTE ISCHEMIC STROKE FROM INTRACRANIAL HEMORRHAGIC STROKE UNIWERSYTET GDANSKI (PL) 2024-06-27 — — WO disclosed
EP-4370150-A1 OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS Intervet International B.V. (NL) 2024-05-22 — — EP disclosed
WO-2023285489-A1 OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS INTERVET INTERNATIONAL B.V. (NL) 2023-01-19 — — WO disclosed
Send feedback